Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $103,787 - $119,327
-525 Reduced 28.0%
1,350 $306,000
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $468,446 - $516,561
-2,330 Reduced 55.41%
1,875 $376,000
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $303,059 - $345,101
-1,430 Reduced 25.38%
4,205 $1.01 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $10,666 - $12,891
-50 Reduced 0.88%
5,635 $1.29 Million
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $1.16 Million - $1.42 Million
5,685 New
5,685 $1.34 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Shorepoint Capital Partners LLC Portfolio

Follow Shorepoint Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shorepoint Capital Partners LLC with notifications on news.